Importantly, the BRCA1-mutation DNAme signature also substantially overlapped with an ER + breast cancer specific risk signature (Additional file 13), which we derived de novo in the UKCTOCS cohort (P <2 x 10-33, Figure 3D). The gene discussed is BRCA1; the disease is breast cancer.